Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8811511 | Journal of Pediatric Urology | 2018 | 5 Pages |
Abstract
Open ureteral reimplantation for recurrent VUR after failed endoscopic injection of a bulking agent was safe and effective, with comparable outcomes and costs to open surgery in patients without prior endoscopic correction.Summary Table. No prior endoscopic treatment (n = 175)Prior endoscopic treatment (n = 17)P-valueReimplanted ureters31131-Median duration of surgery, minutes (range)a144 (46-269)144 (83-334)0.595Median length of stay, days (range)3 (1-17)3 (2-7)0.793Radiographic resolution per ureter (%)b279 (96.2)26 (96.3)0.981Clinical resolution (%)174 (99.4)17 (100)0.755Total charges, USD (range)$12,069 ($5528-45,570)$11,911 ($8756-22,918)0.925Total costs, USD (range)$9876 ($4977-33,315)$9557 ($7321-17,016)0.990OR charges, USD (range)$4930 ($1847-12,359)$5455 ($4007-8093)0.128Select outcomes of open ureteral reimplantation for VUR in patients with and without prior endoscopic correction.aIncludes 145 patients with available data (133 without prior endoscopic treatment, 12 with prior endoscopic treatment).bIncludes 317 reimplanted refluxing ureters (290 without prior endoscopic treatment, 27 with prior endoscopic treatment).
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
D.A. Friedlander, W.W. Ludwig, J.R. Jayman, A. Akhavan,